Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIforex Fin Trad Regulatory News (IFRX)

Share Price Information for Iforex Fin Trad (IFRX)

Share Price is delayed by 15 minutes
Get Live Data
197.00    0.00 (0.00%)
Bid:
196.00
Ask:
198.00
Spread: 2.00 (1.02%)
Market Cap: £43.75m
IFRX Live PriceLast checked at - London Stock Exchange

Intraday Iforex Fin Trad Share Chart

Dividend Declaration

18 Jun 2026 17:04

RNS Number : 8995I
iFOREX Financial Trading Hldgs Ltd
18 June 2026
 

18 June 2026

 

iFOREX Financial Trading Holdings Ltd.

(trading as "iFOREX")

("iFOREX", the "Company" or the "Group")

 

Dividend Declaration

 

iFOREX (LSE:IFRX), a leading fintech business with a proprietary online and mobile trading platform for multi-asset contracts for difference, is pleased to announce that shareholders at the Annual General Meeting of the Company held today approved the declaration of a final dividend of USD 0.055 per ordinary share in the capital of the Company in respect of the financial year ended 31 December 2025.

 

The timetable for the final dividend will be as follows: 

ISIN

GG00BN7RXN80

TIDM

IFRX

Ex-Dividend Date

25 June 2026

Record Date

26 June 2026

Pay Date

24 July 2026

Dividend Type

Final

Dividend Amount & Currency

$0.055 per share

Currency of Dividend payment

USD

 

 

Enquiries:

 

Company Secretary to iFOREX

 

New Street Management Limited

 

 

 

+44 (0) 1481 743030

iforex@nsm.group

 

 

Public Relations Adviser to iFOREX

 

Camarco

Marc Cohen

Phoebe Pugh

 

 

 

 

 

+44 (0)20 3757 4980

iFOREX@camarco.co.uk

 

 

About iFOREX

 

iFOREX is a longestablished broker in the global financial services industry. Founded in 1996, the company operates a proprietary online and mobile trading platform, enabling retail clients to trade Contracts for Difference (CFDs) across more than 870 financial instruments.

 

iFOREX combines advanced technology with a strong focus on customer service, offering free training, support and educational resources to help clients navigate global markets and develop their trading skills.

 

iFOREX Europe is authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC) under license number 143/11 and provides services throughout the European Economic Area (EEA) (with the exception of Belgium and Cyprus) in reliance on ''passports'' granted in accordance with MiFID. The Group also has relevant regulatory authorisations from the Financial Services Commission in the BVI under license number SIBA/L/13/1060.

 

The Group listed on the London Stock Exchange on 25 February 2026 under the ticker LSE: IFRX.

 

For further information, please visit www.iforex.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGPUCUQUPQGQR
Date   Source Headline
18th Jun 20265:04 pmRNSDividend Declaration
18th Jun 20265:03 pmRNSResult of AGM
18th Jun 20267:00 amRNS-RAppointment of Chief Operating Officer
9th Jun 202610:24 amRNSIssue of Equity
20th May 20267:00 amRNSNotice of AGM
30th Apr 20267:00 amRNSAnnual Financial Report
1st Apr 20267:00 amRNSAdmission of Further Securities to Trading and TVR
16th Mar 20265:07 pmRNSIssue of Equity
25th Feb 20267:00 amRNSAdmission to trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.